463 related articles for article (PubMed ID: 29904160)
1. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Hershberger RE; Givertz MM; Ho CY; Judge DP; Kantor PF; McBride KL; Morales A; Taylor MRG; Vatta M; Ware SM;
Genet Med; 2018 Sep; 20(9):899-909. PubMed ID: 29904160
[TBL] [Abstract][Full Text] [Related]
2. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.
Hershberger RE; Givertz MM; Ho CY; Judge DP; Kantor PF; McBride KL; Morales A; Taylor MRG; Vatta M; Ware SM
J Card Fail; 2018 May; 24(5):281-302. PubMed ID: 29567486
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
4. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
5. Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.
Teo LY; Moran RT; Tang WH
Curr Heart Fail Rep; 2015 Dec; 12(6):339-49. PubMed ID: 26472190
[TBL] [Abstract][Full Text] [Related]
6. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.
Ahmad F; McNally EM; Ackerman MJ; Baty LC; Day SM; Kullo IJ; Madueme PC; Maron MS; Martinez MW; Salberg L; Taylor MR; Wilcox JE
Circ Genom Precis Med; 2019 Jun; 12(6):e000054. PubMed ID: 31117808
[TBL] [Abstract][Full Text] [Related]
8. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Stewart DR; Korf BR; Nathanson KL; Stevenson DA; Yohay K
Genet Med; 2018 Jul; 20(7):671-682. PubMed ID: 30006586
[TBL] [Abstract][Full Text] [Related]
9. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA;
Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417
[No Abstract] [Full Text] [Related]
10. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Hershberger RE; Cowan J; Morales A; Siegfried JD
Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
[TBL] [Abstract][Full Text] [Related]
11. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.
Towbin JA; McKenna WJ; Abrams DJ; Ackerman MJ; Calkins H; Darrieux FCC; Daubert JP; de Chillou C; DePasquale EC; Desai MY; Estes NAM; Hua W; Indik JH; Ingles J; James CA; John RM; Judge DP; Keegan R; Krahn AD; Link MS; Marcus FI; McLeod CJ; Mestroni L; Priori SG; Saffitz JE; Sanatani S; Shimizu W; van Tintelen JP; Wilde AAM; Zareba W
Heart Rhythm; 2019 Nov; 16(11):e301-e372. PubMed ID: 31078652
[TBL] [Abstract][Full Text] [Related]
12. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.
Towbin JA; McKenna WJ; Abrams DJ; Ackerman MJ; Calkins H; Darrieux FCC; Daubert JP; de Chillou C; DePasquale EC; Desai MY; Estes NAM; Hua W; Indik JH; Ingles J; James CA; John RM; Judge DP; Keegan R; Krahn AD; Link MS; Marcus FI; McLeod CJ; Mestroni L; Priori SG; Saffitz JE; Sanatani S; Shimizu W; van Tintelen JP; Wilde AAM; Zareba W
Heart Rhythm; 2019 Nov; 16(11):e373-e407. PubMed ID: 31676023
[TBL] [Abstract][Full Text] [Related]
13. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.
Hershberger RE; Lindenfeld J; Mestroni L; Seidman CE; Taylor MR; Towbin JA;
J Card Fail; 2009 Mar; 15(2):83-97. PubMed ID: 19254666
[TBL] [Abstract][Full Text] [Related]
14. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.
Kelly MA; Caleshu C; Morales A; Buchan J; Wolf Z; Harrison SM; Cook S; Dillon MW; Garcia J; Haverfield E; Jongbloed JDH; Macaya D; Manrai A; Orland K; Richard G; Spoonamore K; Thomas M; Thomson K; Vincent LM; Walsh R; Watkins H; Whiffin N; Ingles J; van Tintelen JP; Semsarian C; Ware JS; Hershberger R; Funke B
Genet Med; 2018 Mar; 20(3):351-359. PubMed ID: 29300372
[TBL] [Abstract][Full Text] [Related]
15. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
16. Response to "The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)".
Nussbaum RL; Haverfield E; Esplin ED; Aradhya S
Genet Med; 2019 Dec; 21(12):2836-2837. PubMed ID: 31239557
[No Abstract] [Full Text] [Related]
17. Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.
Yogasundaram H; Alhumaid W; Dzwiniel T; Christian S; Oudit GY
Can J Cardiol; 2021 Apr; 37(4):547-559. PubMed ID: 33493662
[TBL] [Abstract][Full Text] [Related]
18. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
19. [Genetics of inherited cardiomyopathies].
Richard P; Fressart V; Charron P; Hainque B
Pathol Biol (Paris); 2010 Oct; 58(5):343-52. PubMed ID: 19942368
[TBL] [Abstract][Full Text] [Related]
20. Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2015 Sep; 17(9):e3. PubMed ID: 26204421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
